ENAGenomicsInstitute of plant systems biology, TU Münchenhttps://www.ebi.ac.uk/ena/browser/view/PRJNA134699Arabidopsis thalianaComparison of gene expression changes in safener- or BF-treated wild type (Col0) or mutants (tga2tga3tga5tga6, sid2-2) of the salicylic acid signaling pathway. Overall design: Measurements of three biological samples were prepared for each genotype.ENATherapy, treatment, MGC130048, gamma sarcoglycan, Gene Expressions, SGCG_HUMAN, DMDA1, 35 kDa dystrophin-associated glycoprotein, land plants, SG-gamma, Plant, A4, Gene, plants, gamma (35kDa dystrophin-associated glycoprotein), Expressions, Treatments, TYPE, SGCG, LGMD2C, DAGA4, higher plants, disease management., DMDA, Therapeutic, 35kD dystrophin-associated glycoprotein, SCARMD2, 35DAG, Therapies, gamma-sarcoglycan, sarcoglycan, Treatment, Expression, MAM, gamma-SG, SCG3thale cress, mouse-ear cress, thale-cress, Arabidopsis thalianas, Arbisopsis thaliana, Cresses, A., A. thalianas, thalianas, Arabidopsis thaliana, Mouse-ear Cress, Arabidopsis thaliana (thale cress), Arabidopsis., Cress, thaliana, Mouse ear, A. thaliana, Arabidopses, Mouse-ear Cresses, Mouse-ear, Arabis thalianafalseArabidopsis thalianaGene expression changes in wild type, tga2tga3tga5tga6, and sid2-2 plants after treatment with the safeners mefenpyr and isoxadifen2025-09-242014-02-11PRJNA134699GSE254893702